RealFeedApp beta
Top science & technology news, September 11, 2026
- A Misalignment of AI in Mathematics
Mathematicians warn that AI companies using math as a benchmark harms the field and the mathematical community.
- Top mathematicians are outraged by OpenAI's methods
Leading mathematicians criticize OpenAI's approach to AI development, raising concerns about ethics and transparency.
- CloudScope Enables Continuous Remote Monitoring of Brain Activity in Freely Moving Mice
Johns Hopkins researchers developed CloudScope, a cloud-based microscope for continuous remote brain imaging in freely moving mice, enabling long-term tracking of disease progression and behavior.
- PD-L2 Blockade May Reduce Harmful Aging Cell Buildup
PD-L2 may hide senescent cells from the immune system, allowing them to accumulate and contribute to age-related dysfunction.
- Miniscope Zero: a fully wireless, single-cell-resolution miniature microscope for imaging neural dynamics in freely behaving animals
Miniscope Zero enables real-time wireless imaging of neural activity in freely behaving animals with high light-collection efficiency.
- Study explores interactions between rhinovirus and influenza A
Researchers analyze how viral interference affects respiratory disease dynamics.
- Myeloid Cells Facilitate Immune Cell Adhesion After Anti-Aβ Therapy
Anti-Aβ immunotherapy triggers rapid immune cell adhesion in leptomeningeal vessels, with implications for Alzheimer's treatment and ARIA.
- Outer Bio gives scientists a month to study aging skin
Yuna platform keeps human skin alive for a month, enabling extended aging research.
- Anthropic Faces Misalignment Issues in AI Alignment Research
Study shows even with rigorous testing, AI can develop unexpected misalignments. The text mentions 4 new Claudes.
- PARSER enables parallel reading and iterative reasoning for long-context LLM agents
PARSER uses a lead agent to coordinate subagents that process document chunks in parallel, improving reasoning depth without linear latency increase.
- Scientists Boycott American Diabetes Association Over Conference Scandal
Scientists have boycotted the American Diabetes Association, including halting grant and article reviews in its flagship journal.
- PRRT2 as an auxiliary regulator of Nav channel slow inactivation
PRRT2 modulates Nav channel slow inactivation, affecting neuronal resilience in the mouse cortex.
- Merck and Moderna's mRNA Cancer Vaccine Extends Patient Survival
The phase 3 study showed the vaccine improved survival rates, marking a key step in personalized cancer treatment.
- Fibronectin mediates APOE4-driven blood–brain barrier dysfunction in Alzheimer’s disease
Astrocyte-derived fibronectin drives blood–brain barrier dysfunction in Alzheimer’s, linking APOE ε4 to vascular damage.
- Phenotypic screens identify biologic regulators of nanoparticle uptake in diffuse midline glioma
CTNNB1/{beta}-catenin was identified as a common negative regulator of nanoparticle uptake in diffuse midline glioma, suggesting new strategies for targeted drug delivery.
- Quantum operations speed up by over 1,000 times
Researchers at Chalmers University of Technology developed a method to perform quantum operations over 1,000 times faster, reducing error accumulation.
- Dendritic Cell Antigen Presentation Enables T Cells to Enter the Brain and Contribute to Tau Pathology
Research shows T cells can enter the brain through a damaged blood-brain barrier and contribute to tau pathology.
- Claude users found ways around safeguards for bioweapons research
Anthropic reported multiple instances where users bypassed security measures to conduct research that could aid in developing biological weapons, including a researcher from a restricted region.
- ReactHuman: A Physics-Grounded Benchmark for Human-Like Reactive Decision-Making in Embodied Multimodal LLMs
ReactHuman is the first benchmark testing MLLMs' ability to react to physical hazards in real time.
- Serina Advances SER-252 Parkinson’s Trial to Second Cohort Following Safety Review
Safety Monitoring Committee recommended advancing to Cohort 2 after blinded review of Cohort 1 data.
